StockNews.AI
GOCO
StockNews.AI
106 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCO

1. Pomerantz LLP is investigating GoHealth for potential securities fraud. 2. The DOJ filed a False Claims Act complaint against GoHealth on May 1, 2025. 3. GoHealth's stock fell 10.35% to $9.44 following the DOJ lawsuit announcement. 4. Illegal kickbacks to brokers were allegedly paid from 2016 to 2021. 5. Investors are encouraged to join the class action investigation.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The DOJ's allegations of fraud typically lead to significant investor distrust. Historical instances, like those involving Enron and Lehman Brothers, show substantial stock price declines and long-term negative effects following fraud accusations.

How important is it?

The ongoing legal issues could severely impact GoHealth's financial stability, affecting investor sentiment and stock price. Given the seriousness of allegations and the involvement of a high-profile law firm, the likelihood of price impact is significant.

Why Long Term?

Long-term implications are expected due to ongoing investigations and legal consequences. Similar past situations demonstrate that legal uncertainties can negatively affect company valuations and investor confidence over time.

Related Companies

MMDVCNCUNH
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including GoHealth, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, GoHealth’s stock price fell $1.09 per share, or 10.35%, to close at $9.44 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.  CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News